Advertisement
A live audio webcast of the presentation will be available on theInvestors section of the Company's website, www.ilgenetics.com. A replay ofthe presentation will be available on the Interleukin Genetics website for 14days following the presentation.
Advertisement
About Interleukin Genetics
Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalizedhealth company that develops preventive consumer products and genetic testsfor sale to the emerging personalized health market. Focused on the future ofhealth and medicine, Interleukin uses its leading genetics research andscientific capabilities to develop and test innovative preventive andtherapeutic products. Interleukin currently offers an array of Nutraceuticalsand OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which aresold at the nation's largest food, drug and mass retailers, and hascommercialized genetic tests for periodontal disease risk assessment,cardiovascular risk assessment, and general nutrition assessment. Interleukinis headquartered in Waltham, MA. For more information about Interleukin, itsproducts and ongoing programs, please visit www.ilgenetics.com.
SOURCE Interleukin Genetics, Inc.
